United States · FDA National Drug Code directory
VYLOY
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0469-4425_869b812d-b22d-49ed-9d86-c30e4a014a9d
- Product NDC
- 0469-4425
- Form
- INJECTION, POWDER, FOR SUSPENSION
- Composition / generic term
- ZOLBETUXIMAB
- Labeler
- Astellas Pharma US, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20250424
- Source listing expiry
- 20271231
Source-listed ingredients
- ZOLBETUXIMAB — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 BOX (0469-4425-30) / 15 mL in 1 VIAL · 0469-4425-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →